APERTO Lucent MRI System
Fujifilm Corporation · Decision date Sep 16, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 16, 2026 for K261283, the APERTO Lucent MRI System submitted by Fujifilm Corporation under 21 CFR 892.1000, product code LNH, radiology panel. The submission is a traditional 510(k), not reviewed by a third party, and the public record shows no combination product or authorized predetermined change control plan. Clearance is not premarket approval.
The subject device is a 0.4 Tesla permanent-magnet MRI system. Its listed predicate is the APERTO Lucent MRI system cleared as K253862, and the summary states the control and image processing hardware and base software elements are identical to that predicate, with hardware comparisons reported as showing no differences. The summary references a Table 3 analysis of hardware differences, but that table is not included in the supplied excerpts, so the specific changed item and its supporting detail remain unknown.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Sep 16, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261283
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Fujifilm Corporation
- Product code
- LNH
- Decision code
- SESE
- Decision date
- Sep 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Nuclear Magnetic Resonance Imaging.
- Applicant
- Fujifilm Corporation
- Product code
- LNH
- FDA device class
- 2
FDA decision timeline
K261283 received
Application receipt date recorded by FDA.
K261283 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code LNH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MAGNETOM Free.XLK262011 | Siemens Healthineers AG | 510(k) clearance | Nov 5, 2026 | FDA |
ECHELON SynergyK262902 | Fujifilm Corporation | 510(k) clearance | Oct 9, 2026 | FDA |
Vista AI ScanK260092 | Vista AI, Inc. | 510(k) clearance | Oct 7, 2026 | FDA |
SwiftSight-BodyCompositionK261612 | Airs Medical, Inc. | 510(k) clearance | Oct 1, 2026 | FDA |
| Aspect Imaging, Ltd. | 510(k) clearance | Sep 16, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Fujifilm Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Minato-Ku
Sources and methodology
- Original FDA record: K261283
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
